USE OF 1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS Russian patent published in 2021 - IPC C07D471/04 A61K31/437 A61K31/444 A61K31/501 A61K31/506 A61P25/28 

Abstract RU 2759380 C2

FIELD: pharmaceutics.

SUBSTANCE: group of inventions relates to the field of pharmaceutics and includes derivatives of 1H-pyrazolo[4,3-b]pyridine-7-amine of the formula (I), their pharmaceutically acceptable salts, application and pharmaceutical composition based on them. For compounds of the formula (I), L is selected from a group consisting of NH, CH2, S and O; R1 is selected from a group consisting of hydrogen, linear or branched C1-C5alkyl and C1-C5fluoroalkyl; R2 is selected from a group consisting of linear or branched C1-C8alkyl, saturated monocyclic C3-C8cycloalkyl and oxetanyl; R3 is methyl or ethyl substituted with phenyl, pyridonyl, pyridinyl, pyrimidinyl or pyrazinyl, all of which can optionally be substituted with one substituent selected from a group consisting of halogen, C1-C3alkyl, C1-C3fluoroalkyl and C1-C3alkoxy; or R3 is methyl or ethyl substituted with 5-element heteroaryl, which is selected from a group consisting of oxadiazolyl, thiazolyl, oxazolyl, isoxazolyl, triazolyl, pyrazolyl, tetrazolyl, imidazolyl, thiadiazolyl, thiophenyl, which is optionally substituted with one or two substituents selected from C1-C3alkyl and C1-C3fluoroalkyl; or L is CH2, and R3 is NH substituted with phenyl, pyridonyl, pyridinyl or triazolyl, all of which can optionally be substituted with one substituent selected from a group consisting of C1-C3alkyl and C1-C3alkoxy; R4 is phenyl, pyridinyl or pyridonyl, all of which can optionally be substituted with one substituent selected from a group consisting of C1-C4alkyl, C1-C4fluoroalkyl, C1-C3fluoroalkoxy, cyclopropyloxy, C1-C3alkoxy, C1-C3deutherioalkoxy and -N-R5R6, where each of R5 and R6 is independently selected from C1-C3alkyl; or R4 is 5-element heteroaryl, which is pyrazolyl, thiophenyl, thiazolyl, oxazolyl, isoxazolyl, triazolyl, optionally substituted with one or two substituents selected from C1-C4alkyl and -N-R5R6, where each of R5 and R6 is independently selected from H and C1-C3alkyl; or R4 is 4- or 5-element saturated heterocycle selected from a group consisting of oxazolidine-2-one, azetidine-2-one, imidazolidine-2-one, pyrrolidine-2-one, which in all cases can be optionally substituted with one or two substituents selected from oxo and C1-C4alkyl.

EFFECT: compounds of the formula (I) as PDE1 inhibitors.

(I)

16 cl, 1 tbl, 203 ex

Similar patents RU2759380C2

Title Year Author Number
5-AZAINDAZOLE COMPOUNDS AND METHODS FOR USE THEREOF 2013
  • Deu Stiven
  • Khu Khuejyun
  • Kolesnikov Aleksandr
  • Tsui Viki Kh.
  • Van Syaotszin
RU2665462C2
PYRAZOLOPYRIDINE DERIVATIVES AS KINASE INHIBITORS 2015
  • Ford Daniel Dzhejms
  • Ryuberson Dzhejms Tomas
RU2733400C2
PYRAZOLOPYRIDINE DERIVATIVES AS TTX-S BLOCKERS 2013
  • Kavamura Kijosi
  • Yamagisi Tatsuya
  • Arano Josimasa
  • Morita Mikio
RU2652117C2
COMPOUNDS OF PYRIDAZINAMIDE AND THEIR USE AS SYNTHETIC SYNECKINASIS INHIBITORS (SYK) 2013
  • Germann Jokhannes Kornelius
  • Kennedi-Smit Dzhoshua
  • Lukas Metyu S.
  • Pedilla Fernando
  • Sot Majkl
RU2627661C2
DERIVATIVES OF 4-HYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE-1-YL-UREA AND THEIR USE IN TREATMENT, INTER ALIA, DISEASES OF RESPIRATORY TRACT 2011
  • Finch Harry
  • Van Niel Monique Bodil
  • Woo Chi-Kit
RU2586333C1
4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES 2020
  • Dorsch Dieter
  • Blum Andreas
  • Buchstaller Hans-Peter
RU2822388C2
DERIVATIVES OF PYRAZOL PYRIDINE 2004
  • Al'Mansa Rosales Karmen
  • Virkhili Bernado Marina
RU2359971C2
COMPOUNDS TARGETING TAU PROTEIN AND RELATED USE THEREOF 2017
  • Crew, Andrew, P.
  • Berlin, Michael
  • Flanagan, John, J.
  • Dong, Hanqing
  • Ishchenko, Alexey
RU2805523C2
KINASE INHIBITORS 2012
  • Van Niel Monique Bodil
  • Ray Nicholas Charles
  • Alcaraz Lilian
  • Panchal Terry Aaron
  • Jennings Andrew Stephen Robert
  • Armani Elisabetta
  • Cridland Andrew Peter
  • Hurley Christopher
RU2623734C9
SUBSTITUTED 2-AMINOPYRIDINE PROTEIN KINASE INHIBITOR 2014
  • Syao Denmin
  • Syuj Sinkhe
  • Lyu Sitsze
  • Khu Yuandun
  • Yuj Khunkhao
  • Lyu Chzhi Khua
  • Pen Yun
  • Sun Inkhuj
  • Lo Khun
  • Kun Fanshen
  • Khan Yunsin
  • Sun Tszyan
RU2671212C2

RU 2 759 380 C2

Authors

Keler, Yan

Dzhukhl, Karsten

Marigo, Mauro

Vital, Paulo, Khorkhe, Viejra

Dzhessing, Mikkel

Langgard, Morten

Rasmussen, Lars, Kin

Klementson, Karl, Martin, Sebastian

Dates

2021-11-12Published

2017-06-30Filed